Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Liabilities and Shareholders Equity (2016 - 2025)

Dolby Laboratories (DLB) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $3.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 1.06% year-over-year to $3.2 billion, compared with a TTM value of $9.6 billion through Dec 2025, up 4.4%, and an annual FY2025 reading of $3.2 billion, up 3.79% over the prior year.
  • Liabilities and Shareholders Equity was $3.2 billion for Q4 2025 at Dolby Laboratories, down from $3.2 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $3.2 billion in Q1 2025 and bottomed at $2.7 billion in Q3 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $3.0 billion, with a median of $3.1 billion recorded in 2021.
  • The sharpest move saw Liabilities and Shareholders Equity fell 13.4% in 2022, then grew 10.79% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $3.1 billion in 2021, then dropped by 11.48% to $2.7 billion in 2022, then rose by 6.8% to $2.9 billion in 2023, then grew by 7.6% to $3.2 billion in 2024, then grew by 1.06% to $3.2 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for DLB at $3.2 billion in Q4 2025, $3.2 billion in Q3 2025, and $3.2 billion in Q1 2025.